Cargando…

Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial

Objective: To make a comparison between terbinafine 1% cream and ketoconazole 2% cream in the treatment of pityriasis versicolor. Methods: This randomized single blind study included 110 patients with clinical diagnosis of pityriasis versicolor and positive mycological test for Malassezia furfur. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rad, Farrokh, Nik-Khoo, Bahram, Yaghmaee, Roxana, Gharibi, Fardin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publicaitons 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320714/
https://www.ncbi.nlm.nih.gov/pubmed/25674122
http://dx.doi.org/10.12669/pjms.306.5509
_version_ 1782356167912062976
author Rad, Farrokh
Nik-Khoo, Bahram
Yaghmaee, Roxana
Gharibi, Fardin
author_facet Rad, Farrokh
Nik-Khoo, Bahram
Yaghmaee, Roxana
Gharibi, Fardin
author_sort Rad, Farrokh
collection PubMed
description Objective: To make a comparison between terbinafine 1% cream and ketoconazole 2% cream in the treatment of pityriasis versicolor. Methods: This randomized single blind study included 110 patients with clinical diagnosis of pityriasis versicolor and positive mycological test for Malassezia furfur. The patients were randomly assigned to two groups. Group 1 used terbinafine cream and group 2 applied ketoconazole cream on the skin lesions for two weeks. Each group consisted of 55 patients. Clinical and mycological examinations were performed at baseline, at the end of the 2(nd), 4(th) and 8(th) week of starting the treatment regimens. Results: At the end of the 2(nd) week we achieved cure rates of 72% and 64.3% for group 1 and group 2 respectively. At the end of the 4(th) week the respective cure rates for group 1 and group 2 were 81.2% and 69%, and at the end of the 8(th) week 70.8% of the patients in group 1 and 61.9% of the patients in group 2 were cured. Conclusion: The results of this study showed no significant statistical differences between the two groups in regard to cure and recurrence rates. But the numbers of cured patients were higher and recurrent cases were lower in group 1.
format Online
Article
Text
id pubmed-4320714
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Professional Medical Publicaitons
record_format MEDLINE/PubMed
spelling pubmed-43207142015-02-11 Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial Rad, Farrokh Nik-Khoo, Bahram Yaghmaee, Roxana Gharibi, Fardin Pak J Med Sci Original Article Objective: To make a comparison between terbinafine 1% cream and ketoconazole 2% cream in the treatment of pityriasis versicolor. Methods: This randomized single blind study included 110 patients with clinical diagnosis of pityriasis versicolor and positive mycological test for Malassezia furfur. The patients were randomly assigned to two groups. Group 1 used terbinafine cream and group 2 applied ketoconazole cream on the skin lesions for two weeks. Each group consisted of 55 patients. Clinical and mycological examinations were performed at baseline, at the end of the 2(nd), 4(th) and 8(th) week of starting the treatment regimens. Results: At the end of the 2(nd) week we achieved cure rates of 72% and 64.3% for group 1 and group 2 respectively. At the end of the 4(th) week the respective cure rates for group 1 and group 2 were 81.2% and 69%, and at the end of the 8(th) week 70.8% of the patients in group 1 and 61.9% of the patients in group 2 were cured. Conclusion: The results of this study showed no significant statistical differences between the two groups in regard to cure and recurrence rates. But the numbers of cured patients were higher and recurrent cases were lower in group 1. Professional Medical Publicaitons 2014 /pmc/articles/PMC4320714/ /pubmed/25674122 http://dx.doi.org/10.12669/pjms.306.5509 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Rad, Farrokh
Nik-Khoo, Bahram
Yaghmaee, Roxana
Gharibi, Fardin
Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial
title Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial
title_full Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial
title_fullStr Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial
title_full_unstemmed Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial
title_short Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial
title_sort terbinafin 1% cream and ketoconazole 2% cream in the treatment of pityriasis versicolor: a randomized comparative clinical trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320714/
https://www.ncbi.nlm.nih.gov/pubmed/25674122
http://dx.doi.org/10.12669/pjms.306.5509
work_keys_str_mv AT radfarrokh terbinafin1creamandketoconazole2creaminthetreatmentofpityriasisversicolorarandomizedcomparativeclinicaltrial
AT nikkhoobahram terbinafin1creamandketoconazole2creaminthetreatmentofpityriasisversicolorarandomizedcomparativeclinicaltrial
AT yaghmaeeroxana terbinafin1creamandketoconazole2creaminthetreatmentofpityriasisversicolorarandomizedcomparativeclinicaltrial
AT gharibifardin terbinafin1creamandketoconazole2creaminthetreatmentofpityriasisversicolorarandomizedcomparativeclinicaltrial